This coming (and the following half) report will be very interesting.
Interest in their Promensil drug has increased dramatically (words from NRT) and they're getting closer to releasing more results from the anti-cancer drug.
Valued at a little more than 100m market cap it could be worth a punt. Ive also noticed the market depth filling up on the buy side (still thin but alot better than a week ago).
I've written to the company requesting details on Promensil sales/royalty structure. I'll post the details here as soon as I receive them.
Cheers,
Munch.
Novogen - Cheap Biotech play
Add KZA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
82.0¢ |
Change
0.020(2.50%) |
Mkt cap ! $109.8M | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 82.0¢ | 78.5¢ | $10.17K | 12.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6200 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.0¢ | 1970 | 1 |
View Market Depth
| Last trade - 15.47pm 26/05/2022 (20 minute delay) ? |
 (live)
|
|||||
|
Last
80.0¢ |
Change
0.020 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 80.0¢ | 80.0¢ | 80.0¢ | 1 | ||
| Last updated 12.27pm 26/05/2022 (live) ? | |||||
| KZA (ASX) Chart |